MRFF funding to advance research into blood cancer and neurological conditions in children
The Commonwealth Government’s Medical Research Future Fund (MRFF) has invested close to $8 million to advance neurological and cancer research led by Monash University’s Faculty of Medicine, Nursing and Health Sciences.
In Roe v Wade’s shadow, there’s an urgent need to tackle abortion stigma in Australia
In an exploratory interview study about the timely topic of abortion, Australian women and pregnancy-capable people spoke about their recent experiences seeking abortion care.
COVID study wins Trial of the Year award
The incredible contributions to understanding how to treat COVID made by the REMAP-CAP trial have been recognised, as the researchers walked away from yesterday’s Australian Clinical Trials Alliance annual award ceremony with the Trial of the
Supporting better healthcare for immunocompromised youth
Adolescents and young adults have been hard hit by the COVID-19 pandemic. It’s severely disrupted education, thwarted important socialisation opportunities and life milestone celebrations, and employment opportunities have evaporated as a
RACP College Medal awarded to renowned women’s health researcher
Huge congratulations to the Head of our Women’s Health Research Program, researcher and endocrinologist Professor Susan Davis AO, on recently receiving the annual College Medal from the Royal Australian College of Physicians.
Joining the dots on joint health and heart health
A new study underlines the importance of preventing weight gain versus weight reduction, and the interconnectedness of joint health and heart heath.
New genetic risk assessment for osteoarthritis may reduce joint replacements
A new risk assessment tool validated by researchers at the Monash School of Public Health and Preventive Medicine may help reduce the need for knee and hip replacements among osteoarthritis (OA) patients.
New study to improve gastric cancer diagnosis in Victoria
A newly-funded project led by our Cancer Research Program is set to determine whether patients with advanced gastric (stomach) cancer in Victoria are all being tested for HER2 status using the recommended criteria at the time of their diagnosis.